{
    "clinical_study": {
        "@rank": "107661", 
        "arm_group": {
            "arm_group_label": "Salpingography", 
            "arm_group_type": "Experimental", 
            "description": "Infusion of air bubbles through Fallopian tubes with hysteroscopic visualization; typically 1-2 mL is infused. This is less than that typically used in the established technique of sonosalpingography."
        }, 
        "brief_summary": {
            "textblock": "Disease of the fallopian tubes is one of the most common reasons for infertility. The most\n      common test, a hysterosalpingogram, tends to be painful,inconvenient, and frequently misses\n      concurrent uterine disease. We propose using a less painful technique (through modified\n      office hysteroscopy) for tubal assessment that can be performed in the office rather than\n      hospital radiology and that uses gold standard technology for identifying coexisting uterine\n      conditions."
        }, 
        "brief_title": "Hysteroscopic Assessment of Fallopian Tubal Patency", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Infertility", 
            "Menorrhagia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Infertility", 
                "Menorrhagia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. 18 - 50 years old\n\n          2. Able to give consent\n\n          3. Must have a uterus\n\n          4. Must have documented negative testing for gonorrhea and chlamydia within the past\n             year or previously negative when tested with a current partner in a monogamous\n             relationship\n\n          5. Negative test prior to procedure\n\n        Exclusion Criteria:\n\n          1. Pregnancy\n\n          2. Active lower and upper genital tract infection\n\n          3. Patients with allergies to hysterosalpingogram contrast will not be exposed to a\n             contrast material to which they are allergic\n\n          4. Premenarchal or postmenopausal\n\n          5. Unable to read English at a 6th grade level or above"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02005263", 
            "org_study_id": "2013-0230"
        }, 
        "intervention": {
            "arm_group_label": "Salpingography", 
            "description": "Infusion of typically 1-2 mL of air bubbles in to the uterine cavity to assess whether they disappear through the ostia in to the Fallopian tubes.", 
            "intervention_name": "Salpingography", 
            "intervention_type": "Procedure", 
            "other_name": "Parryscope technique"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Hysteroscopy", 
        "lastchanged_date": "December 16, 2013", 
        "location": {
            "contact": {
                "email": "JParry2@umc.edu", 
                "last_name": "John P Parry, MD", 
                "phone": "601-984-5330"
            }, 
            "facility": {
                "address": {
                    "city": "Jackson", 
                    "country": "United States", 
                    "state": "Mississippi", 
                    "zip": "39216"
                }, 
                "name": "University of Mississippi Medical Center"
            }, 
            "investigator": {
                "last_name": "John P. Parry, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Hysteroscopic Assessment of Fallopian Tubal Patency", 
        "overall_contact": {
            "email": "JParry2@umc.edu", 
            "last_name": "John P. Parry, MD", 
            "phone": "601-984-5330"
        }, 
        "overall_official": {
            "affiliation": "University of Mississippi Medical Center", 
            "last_name": "John P. Parry, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patients undergoing the procedure will be informed based on the findings as to whether or not it is believed that their Fallopian tubes are patent", 
            "measure": "Hysteroscopic assessment of tubal patency", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02005263"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Mississippi Medical Center", 
            "investigator_full_name": "John Preston Parry, MD, MPH", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Mississippi Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Mississippi Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}